Author:
Zechel Jennifer L,Doerner Stephanie K,Lager Angela,Tesar Paul J,Heaney Jason D,Nadeau Joseph H
Abstract
Abstract
Background
Certain mutations in the Deadend1 (Dnd1) gene are the most potent modifiers of testicular germ cell tumor (TGCT) susceptibility in mice and rats. In the 129 family of mice, the Dnd1
Ter
mutation significantly increases occurrence of TGCT-affected males. To test the hypothesis that he Dnd1
Ter
allele is a loss-of-function mutation; we characterized the consequences of a genetically-engineered loss-of-function mutation in mice, and compared these results with those for Dnd1
Ter
.
Results
We found that intercrossing Dnd1
+/KO
heterozygotes to generate a complete loss-of-function led to absence of Dnd1
KO/KO
homozygotes and significantly reduced numbers of Dnd1
+/KO
heterozygotes. Further crosses showed that Dnd1
Ter
partially rescues loss of Dnd1
KO
mice. We also found that loss of a single copy of Dnd1 in Dnd1
KO/+
heterozygotes did not affect baseline occurrence of TGCT-affected males and that Dnd1
Ter
increased TGCT risk regardless whether the alternative allele was loss-of-function (Dnd1
KO
) or wild-type (Dnd1
+
). Finally, we found that the action of Dnd1
Ter
was not limited to testicular cancer, but also significantly increased polyp number and burden in the Apc
+/Min
model of intestinal polyposis.
Conclusion
These results show that Dnd1 is essential for normal allelic inheritance and that Dnd1
Ter
has a novel combination of functions that significantly increase risk for both testicular and intestinal cancer.
Publisher
Springer Science and Business Media LLC
Subject
Genetics (clinical),Genetics
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献